It has been proposed that D5W relieves pain through a sensorineural mechanism by downregulating transient receptor potential vanilloid receptor 1 (TRPV-1), which is often upregulated in cases of chronic neuropathic pain [64]. The gene discussed is TRPV1; the disease is neuropathic pain.